• Citer

Sequential versus alternating administration of cisplatin/etoposide and topotecan as first-line treatment in extensive-stage small-cell lung cancer: preliminary results of a Phase III Trial of the Hellenic Oncology Research Group.

par Ignatiadis, Michail ;Mavroudis, Dimitris;Veslemes, Marinos;Boukovinas, John;Syrigos, Kostas;Agelidou, Maria;Agelidou, Athina;Gerogianni, Aleka;Pavlakou, Georgia;Tselepatiotis, Evaggelos;Nikolakopoulos, John;Georgoulias, Vassilis
Référence Clinical lung cancer, 7, 3, page (183-189)
Publication Publié, 2005-11

Article révisé par les pairs

• Détails
• Contenu

Titre:	Sequential versus alternating administration of cisplatin/etoposide and topotecan as first-line treatment in extensive-stage small-cell lung cancer: preliminary results of a Phase III Trial of the Hellenic Oncology Research Group.
Auteur:	Ignatiadis, Michail; Mavroudis, Dimitris; Veslemes, Marinos; Boukovinas, John; Syrigos, Kostas; Agelidou, Maria; Agelidou, Athina; Gerogianni, Aleka; Pavlakou, Georgia; Tselepatiotis, Evaggelos; Nikolakopoulos, John; Georgoulias, Vassilis
Informations sur la publication:	Clinical lung cancer, 7, 3, page (183-189)
Statut de publication:	Publié, 2005-11
Sujet CREF:	Cancérologie
	Médecine pathologie humaine
	Sciences bio-médicales et agricoles
MeSH keywords:	Adult
	Aged
	Antineoplastic Combined Chemotherapy Protocols -- administration & dosage -- adverse effects
	Carcinoma, Small Cell -- drug therapy -- mortality
	Cisplatin -- administration & dosage -- adverse effects
	Drug Administration Schedule
	Etoposide -- administration & dosage -- adverse effects
	Female
	Humans
	Injections, Intravenous
	Lung Neoplasms -- drug therapy -- mortality
	Male
	Middle Aged
	Survival Analysis
	Topotecan -- administration & dosage -- adverse effects
Langue:	Anglais
Identificateurs:	urn:issn:1525-7304
	info:doi/10.3816/CLC.2005.n.034
	info:pii/S1525-7304(11)70409-0
	info:pmid/16354313